Resultados de Búsqueda

Cochrane Quality and Productivity topics

National Institute for Health and Clinical Excellence (NICE)

"NICE summary of review conclusions

Evidence shows that the majority of relapse prevention interventions for smoking cessation are not effective and should not be used. There is not enough evidence to recommend behavioural methods routinely to prevent smoking relapse in people who have achieved abstinence for circumstantial reasons; such as pregnancy, being an inpatient in hospital or recruited into the military; or decided to quit unaided. There is also little evidence that ...

Cochrane Quality and Productivity topics

National Institute for Health and Clinical Excellence (NICE)

"Evidence shows that biofeedback for treating functional faecal incontinence is not effective in children and should not be used. NICE has previously recommended against the use of biofeedback to treat functional constipation; but biofeedback also demonstrates no efficacy in non-retentive functional incontinence. It is appropriate to focus resources on interventions for which there is evidence of efficacy, including other behavioural interventions and laxative use."

Cochrane Quality and Productivity topics

National Institute for Health and Clinical Excellence (NICE)

"NICE summary of Cochrane review conclusions The current level of evidence does not support the routine measurement of fractional exhaled nitric oxide (FENO) to tailor corticosteroid therapy in adults or children with asthma. Tailoring the dose of inhaled corticosteroids (ICS) based on FENO did not significantly reduce exacerbations or improve forced expiratory volume in one second (FEV1) or asthma symptoms. In addition the use of FENO to tailor ICS dose in children was associated with higher ...

Cochrane Quality and Productivity topics

National Institute for Health and Clinical Excellence (NICE)

"NICE summary of Cochrane review conclusions Evidence does not support the routine use of inhaled corticosteroids (ICS) as anti-inflammatory agents in children and adults with cystic fibrosis (CF). There is no evidence of objective improvements in lung function or subjective improvements in exercise tolerance or quality of life. ICS should only be used for the symptomatic relief of recurrent wheezing that is not responsive to bronchodilators alone. Outside of this indication they are likely ...

Cochrane Quality and Productivity topics

National Institute for Health and Clinical Excellence (NICE)

"Evidence shows that mesalazine and olsalazine are not effective for the induction of remission in Crohn’s disease and should not be used. Sulfasalazine may be beneficial in patients with disease confined to the colon but not in more extensive disease. Sulfasalazine can be considered along with other first-line drugs for the treatment of colonic Crohn’s disease. However, mesalazine and olsalazine are not effective and a different first-line treatment should be substituted for the induction ...